Bone Biologics (BBLG) Current Assets (2013 - 2025)
Bone Biologics (BBLG) reported Current Assets of $5.8 million for Q4 2025, up 50.11% year-over-year from $3.9 million in Q4 2024, and down 8.73% quarter-over-quarter from $6.4 million in Q3 2025.
Bone Biologics (BBLG) Current Assets (2013 - 2025) Analysis & Trends
Bone Biologics (BBLG) has 12 years of Current Assets data on file, last reported at $5.8 million in Q4 2025.
- Current Assets for Q4 2025 came in at $5.8 million, up 50.11% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.8 million (up 50.11% YoY), and the FY2025 annual result was $5.8 million, up 50.11% from the prior year.
- Current Assets fell to $5.8 million in Q4 2025 per BBLG's latest filing, from $6.4 million in the prior quarter.
- Over five years, Current Assets peaked at $8.5 million in Q4 2022 and troughed at $3.2 million in Q1 2025.
- A 4-year average of $5.0 million and a median of $4.0 million in 2024 frame the typical range for Current Assets.
- The sharpest annual moves came in 2023 and 2025: Current Assets sank 56.0% in 2023, then jumped 119.27% in 2025.
- A 4-year view of Current Assets shows it stood at $8.5 million in 2022, then slumped by 56.0% to $3.7 million in 2023, then rose by 3.31% to $3.9 million in 2024, then soared by 50.11% to $5.8 million in 2025.
- Business Quant data shows BBLG's Current Assets at $5.8 million in Q4 2025, $6.4 million in Q3 2025, and $7.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 3.59 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 600.85 Mn |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - | 5.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.80 Mn |
| Sep 30, 2025 | 6.35 Mn |
| Jun 30, 2025 | 7.00 Mn |
| Mar 31, 2025 | 3.16 Mn |
| Dec 31, 2024 | 3.86 Mn |
| Sep 30, 2024 | 4.07 Mn |
| Jun 30, 2024 | 3.19 Mn |
| Mar 31, 2024 | 3.84 Mn |
| Dec 31, 2023 | 3.74 Mn |
| Dec 31, 2022 | 8.50 Mn |
| Sep 30, 2020 | 2,461.00 |
| Jun 30, 2020 | 1,433.00 |
| Dec 31, 2019 | 30,827.00 |
| Sep 30, 2019 | 249,345.00 |
| Jun 30, 2019 | 266,395.00 |
| Mar 31, 2019 | 814,063.00 |
| Dec 31, 2018 | 1.04 Mn |
| Sep 30, 2018 | 2.35 Mn |
| Jun 30, 2018 | 377,646.00 |
| Mar 31, 2018 | 470,373.00 |